Hikma Pharmaceuticals PLC (HIK) — Tangible Net Worth Ratio
Hikma Pharmaceuticals PLC (HIK) has a Tangible Net Worth Ratio of 67.7% as of June 2025. This metric is calculated by deducting intangible assets (GBX824.00 Million) from net assets (GBX2.55 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Hikma Pharmaceuticals PLC shareholders equity for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Hikma Pharmaceuticals PLC Tangible Net Worth Ratio (2002–2024)
This chart shows how Hikma Pharmaceuticals PLC's Tangible Net Worth Ratio has changed across 23 annual periods from 2002 to 2024. As of June 2025, the ratio stands at 67.7%, reflecting net assets of GBX2.55 Billion with intangible assets of GBX824.00 Million GBX. Also explore how fast is Hikma Pharmaceuticals PLC growing its equity to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Hikma Pharmaceuticals PLC (2002–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Hikma Pharmaceuticals PLC from 2002 to 2024, covering 23 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Hikma Pharmaceuticals PLC market cap and net worth.
| Year | Tangible NW Ratio | Net Assets (GBX) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 66.7% | GBX2.32 Billion | GBX774.00 Million | GBX5.13 Billion | ▼ -1.1 pp |
| 2023 | 67.8% | GBX2.21 Billion | GBX712.00 Million | GBX4.68 Billion | ▲ +2.0 pp |
| 2022 | 65.8% | GBX2.15 Billion | GBX735.00 Million | GBX4.47 Billion | ▼ -9.6 pp |
| 2021 | 75.4% | GBX2.47 Billion | GBX607.00 Million | GBX4.37 Billion | ▲ +2.7 pp |
| 2020 | 72.7% | GBX2.15 Billion | GBX587.00 Million | GBX4.13 Billion | ▼ -1.4 pp |
| 2019 | 74.1% | GBX2.13 Billion | GBX552.00 Million | GBX3.93 Billion | ▲ +2.8 pp |
| 2018 | 71.3% | GBX1.70 Billion | GBX487.00 Million | GBX3.50 Billion | ▲ +4.2 pp |
| 2017 | 67.1% | GBX1.53 Billion | GBX503.00 Million | GBX3.39 Billion | ▲ +10.1 pp |
| 2016 | 57.0% | GBX2.41 Billion | GBX1.04 Billion | GBX4.36 Billion | ▼ -19.7 pp |
| 2015 | 76.7% | GBX1.35 Billion | GBX315.00 Million | GBX2.60 Billion | ▲ +0.4 pp |
| 2014 | 76.3% | GBX1.22 Billion | GBX288.00 Million | GBX2.25 Billion | ▼ -7.3 pp |
| 2013 | 83.7% | GBX1.03 Billion | GBX169.00 Million | GBX1.93 Billion | ▲ +3.2 pp |
| 2012 | 80.4% | GBX847.85 Million | GBX166.03 Million | GBX1.73 Billion | ▲ +31.6 pp |
| 2011 | 48.8% | GBX798.63 Million | GBX408.80 Million | GBX1.58 Billion | ▼ -15.3 pp |
| 2010 | 64.1% | GBX750.30 Million | GBX269.12 Million | GBX1.12 Billion | ▲ +1.6 pp |
| 2009 | 62.6% | GBX683.26 Million | GBX255.70 Million | GBX1.02 Billion | ▲ +5.0 pp |
| 2008 | 57.6% | GBX609.00 Million | GBX258.23 Million | GBX966.46 Million | ▲ +18.8 pp |
| 2007 | 38.8% | GBX424.66 Million | GBX259.84 Million | GBX894.04 Million | ▼ -56.9 pp |
| 2006 | 95.7% | GBX349.80 Million | GBX15.02 Million | GBX488.36 Million | ▼ -1.6 pp |
| 2005 | 97.3% | GBX287.48 Million | GBX7.74 Million | GBX397.96 Million | ▲ +0.8 pp |
| 2004 | 96.5% | GBX145.18 Million | GBX5.03 Million | GBX246.48 Million | ▼ -2.8 pp |
| 2003 | 99.3% | GBX60.47 Million | GBX416.00K | GBX117.86 Million | ▲ +0.4 pp |
| 2002 | 99.0% | GBX48.03 Million | GBX503.00K | GBX94.86 Million | — |